After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Gilead Sciences, Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – General industry. The current market capitalization of Gilead Sciences, Inc is $144.55B. A total of 10.01 million shares were traded on the day, compared to an average of 7.27M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, GILD has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, MERDAD V PARSEY bought 21,910 shares of GILD for 115.70 per share on Mar 03 ’25. In a previous transaction on Feb 18 ’25, GILEAD SCIENCES, INC. bought 1,363,636 shares at 11.00 per share. GILD shares that 10% Owner owns now total 31,424,760.
Among the insiders who sold shares, Dickinson Andrew D disposed of 2,500 shares on Feb 18 ’25 at a per-share price of $104.09. This resulted in the Chief Financial Officer holding 169,061 shares of GILD after the transaction. In another insider transaction, ANDREW DICKINSON bought 2,500 shares at $104.09 per share on Feb 18 ’25.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Gilead Sciences, Inc pays an annual dividend of $3.08, resulting in a dividend yield of 2.66%, and it has a price to earnings (P/E) ratio of 315.96. GILD’s most recent ex-dividend date was 3% when it declared a $0.79 quarterly dividend that was paid in cash on 3/14/2025. Previously, the company paid the dividend on 12/13/2024 with an ex-dividend date of 3.15%. The GILD stock dividend was $0.77 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for GILD in the last 3 months, the mean price target is $109.29 with high estimates of $130.00 and low estimates of $82.00. In terms of 52-week highs and lows, GILD has a high of $114.77 and a low of $62.07.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. GILD’s latest balance sheet shows that the firm has $6.52B in Cash & Short Term Investments as of fiscal 2021. There were $26.70B in debt and $11.61B in liabilities at the time. Its Book Value Per Share was $15.51, while its Total Shareholder’s Equity was $21.06B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GILD is Buy with a score of 4.31.
